سوق الرعاية الحرجة العالمي القائم على الذكاء الاصطناعي - اتجاهات الصناعة والتوقعات حتى عام 2029

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 MARKET GUIDE

2.2.4 COMPANY POSITIONING GRID

2.2.5 COMPANY MARKET SHARE ANALYSIS

2.2.6 MULTIVARIATE MODELLING

2.2.7 TOP TO BOTTOM ANALYSIS

2.2.8 STANDARDS OF MEASUREMENT

2.2.9 VENDOR SHARE ANALYSIS

2.2.10 SALES VOLUME

2.2.11 EPIDEMIOLOGY MODELLING

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTAL ANALYSIS

5.2 PORTER’S FIVE FORCES

5.3 KEY STRATEGIC INITIATIVES

6 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY OFFERING

6.1 OVERVIEW

6.2 HARDWARE

6.2.1 VENTILATORS

6.2.1.1. MARKET VALUE (USD MILLION)

6.2.1.2. MARKET VOLUME (UNITS)

6.2.1.3. AVERAGE SELLING PRICE (USD)

6.2.2 DRUG MANAGEMENT SYSTEM

6.2.2.1. MARKET VALUE (USD MILLION)

6.2.2.2. MARKET VOLUME (UNITS)

6.2.2.3. AVERAGE SELLING PRICE (USD)

6.2.3 VITAL MONITORING SYSTEM

6.2.3.1. MARKET VALUE (USD MILLION)

6.2.3.2. MARKET VOLUME (UNITS)

6.2.3.3. AVERAGE SELLING PRICE (USD)

6.2.4 INFUSION PUMPS

6.2.4.1. MARKET VALUE (USD MILLION)

6.2.4.2. MARKET VOLUME (UNITS)

6.2.4.3. AVERAGE SELLING PRICE (USD)

6.2.5 ECG DEVICES

6.2.5.1. MARKET VALUE (USD MILLION)

6.2.5.2. MARKET VOLUME (UNITS)

6.2.5.3. AVERAGE SELLING PRICE (USD)

6.2.6 OTHERS

6.3 SOFTWARE

6.3.1 DATA AGGREGATION

6.3.2 DATA INTEGRATION

6.3.3 DATA ANALYTICS

6.3.3.1. DATA COLLECTION

6.3.3.2. DATA ACCESS

6.3.3.3. DATA WAREHOUSING

6.3.3.4. DATA MINING

6.3.4 DATA VISUALIZATION

6.3.5 OTHERS

6.4 SERVICES

6.4.1 BY SERVICE TYPE

6.4.1.1. TELE-CONSULATATION

6.4.1.1.1. CENTRALIZED TELE-ICU

6.4.1.1.2. DECENTRALIZED TELE-ICUHYBRID TELE-ICU

6.4.1.2. CRITICAL-CARE NURSING

6.4.1.3. HEALTH ATTENDANT

6.4.1.4. PATIENT VITAL MONITORING SUPPORT

6.4.1.5. OTHERS

6.4.2 BY DISEASE TYPE

6.4.2.1. NEUROLOGY

6.4.2.2. CANCER (INCLUDING PALLIATIVE CARE)

6.4.2.3. PULMONOLOGY

6.4.2.4. CARDIAC

6.4.2.5. NEPHROLOGY

6.4.2.6. OTHERS

6.5 OTHERS

7 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 MACHINE LEARNING

7.3 CONTEXT-AWARE COMPUTING

7.4 NATURAL LANGUAGE PROCESSING

7.5 COMPUTER VISION

7.6 SPEECH RECOGNITION

7.7 QUERYING METHOD

8 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 HEALTH MONITORING

8.2.1 HARDWARE

8.2.2 SOFTWARE

8.2.3 SERVICES

8.3 DIGITAL CONSULTATION

8.3.1 HARDWARE

8.3.2 SOFTWARE

8.3.3 SERVICES

8.4 VIRTUAL NURSES

8.4.1 HARDWARE

8.4.2 SOFTWARE

8.4.3 SERVICES

8.5 PRECISION MEDICINE

8.5.1 HARDWARE

8.5.2 SOFTWARE

8.5.3 SERVICES

8.6 DRUG CREATION

8.6.1 HARDWARE

8.6.2 SOFTWARE

8.6.3 SERVICES

8.7 HEALTHCARE SYSTEM ANALYSIS

8.7.1 HARDWARE

8.7.2 SOFTWARE

8.7.3 SERVICES

8.8 MEDICATION MANAGEMENT

8.8.1 HARDWARE

8.8.2 SOFTWARE

8.8.3 SERVICES

8.9 OTHERS

9 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 AMBULATORY SURGICAL CENTERS

9.4 SPECIALTY CLINICS

9.5 OTHERS

10 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDER

10.3 THIRD PARTY DISTRIBUTORS

10.4 OTHERS

11 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY REGION

GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.1.1. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY OFFERING

11.1.1.2. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY TECHNOLOGY

11.1.1.3. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY APPLICATION

11.1.1.4. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY END USER

11.1.1.5. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY DISTRIBUTION CHANNEL

11.1.2 CANADA

11.1.3 MEXICO

11.2 EUROPE

11.2.1 GERMANY

11.2.2 FRANCE

11.2.3 U.K.

11.2.4 ITALY

11.2.5 SPAIN

11.2.6 RUSSIA

11.2.7 TURKEY

11.2.8 BELGIUM

11.2.9 DENMARK

11.2.10 NETHERLANDS

11.2.11 SWITZERLAND

11.2.12 SWEDEN

11.2.13 POLAND

11.2.14 NORWAY

11.2.15 FINLAND

11.2.16 REST OF EUROPE

11.3 ASIA-PACIFIC

11.3.1 JAPAN

11.3.2 CHINA

11.3.3 SOUTH KOREA

11.3.4 INDIA

11.3.5 AUSTRALIA

11.3.6 NEW ZEALAND

11.3.7 SINGAPORE

11.3.8 THAILAND

11.3.9 MALAYSIA

11.3.10 VIETNAM

11.3.11 TAIWAN

11.3.12 INDONESIA

11.3.13 PHILIPPINES

11.3.14 REST OF ASIA-PACIFIC

11.4 SOUTH AMERICA

11.4.1 BRAZIL

11.4.2 ARGENTINA

11.4.3 REST OF SOUTH AMERICA

11.5 MIDDLE EAST AND AFRICA

11.5.1 SOUTH AFRICA

11.5.2 SAUDI ARABIA

11.5.3 BAHRAIN

11.5.4 UAE

11.5.5 KUWAIT

11.5.6 OMAN

11.5.7 QATAR

11.5.8 EGYPT

11.5.9 ISRAEL

11.5.10 REST OF MIDDLE EAST AND AFRICA

11.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, SWOT AND DBMR ANALYSIS

13 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3 COMPANY SHARE ANALYSIS: EUROPE

13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13.5 MERGERS & ACQUISITIONS

13.6 NEW PRODUCT DEVELOPMENT & APPROVALS

13.7 EXPANSIONS

13.8 REGULATORY CHANGES

13.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

14 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, COMPANY PROFILE

14.1 AUTONOMOUS HEALTHCARE

14.1.1 COMPANY OVERVIEW

14.1.2 REVENUE ANALYSIS

14.1.3 GEOGRAPHIC PRESENCE

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 TORADEX SYSTEMS (INDIA) PVT. LTD.

14.2.1 COMPANY OVERVIEW

14.2.2 REVENUE ANALYSIS

14.2.3 GEOGRAPHIC PRESENCE

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 BAXTER

14.3.1 COMPANY OVERVIEW

14.3.2 REVENUE ANALYSIS

14.3.3 GEOGRAPHIC PRESENCE

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 WELLUE

14.4.1 COMPANY OVERVIEW

14.4.2 REVENUE ANALYSIS

14.4.3 GEOGRAPHIC PRESENCE

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 ANUMANA, INC.

14.5.1 COMPANY OVERVIEW

14.5.2 REVENUE ANALYSIS

14.5.3 GEOGRAPHIC PRESENCE

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 XORESEARCH

14.6.1 COMPANY OVERVIEW

14.6.2 REVENUE ANALYSIS

14.6.3 GEOGRAPHIC PRESENCE

14.6.4 PRODUCT PORTFOLIO

14.6.5 RECENT DEVELOPMENTS

14.7 ALIVECOR, INC.

14.7.1 COMPANY OVERVIEW

14.7.2 REVENUE ANALYSIS

14.7.3 GEOGRAPHIC PRESENCE

14.7.4 PRODUCT PORTFOLIO

14.7.5 RECENT DEVELOPMENTS

14.8 LEPU MEDICAL

14.8.1 COMPANY OVERVIEW

14.8.2 REVENUE ANALYSIS

14.8.3 GEOGRAPHIC PRESENCE

14.8.4 PRODUCT PORTFOLIO

14.8.5 RECENT DEVELOPMENTS

14.9 ETIOMETRY, INC.

14.9.1 COMPANY OVERVIEW

14.9.2 REVENUE ANALYSIS

14.9.3 GEOGRAPHIC PRESENCE

14.9.4 PRODUCT PORTFOLIO

14.9.5 RECENT DEVELOPMENTS

14.1 NETEERA

14.10.1 COMPANY OVERVIEW

14.10.2 REVENUE ANALYSIS

14.10.3 GEOGRAPHIC PRESENCE

14.10.4 PRODUCT PORTFOLIO

14.10.5 RECENT DEVELOPMENTS

14.11 VITLS

14.11.1 COMPANY OVERVIEW

14.11.2 REVENUE ANALYSIS

14.11.3 GEOGRAPHIC PRESENCE

14.11.4 PRODUCT PORTFOLIO

14.11.5 RECENT DEVELOPMENTS

14.12 APOLLO TELEHEALTH

14.12.1 COMPANY OVERVIEW

14.12.2 REVENUE ANALYSIS

14.12.3 GEOGRAPHIC PRESENCE

14.12.4 PRODUCT PORTFOLIO

14.12.5 RECENT DEVELOPMENTS

14.13 EAGLE TELEMEDICINE

14.13.1 COMPANY OVERVIEW

14.13.2 REVENUE ANALYSIS

14.13.3 GEOGRAPHIC PRESENCE

14.13.4 PRODUCT PORTFOLIO

14.13.5 RECENT DEVELOPMENTS

14.14 GE HEALTHCARE

14.14.1 COMPANY OVERVIEW

14.14.2 REVENUE ANALYSIS

14.14.3 GEOGRAPHIC PRESENCE

14.14.4 PRODUCT PORTFOLIO

14.14.5 RECENT DEVELOPMENTS

14.15 HICUITY HEALTH

14.15.1 COMPANY OVERVIEW

14.15.2 REVENUE ANALYSIS

14.15.3 GEOGRAPHIC PRESENCE

14.15.4 PRODUCT PORTFOLIO

14.15.5 RECENT DEVELOPMENTS

14.16 INTERCEPT TELEMED

14.16.1 COMPANY OVERVIEW

14.16.2 REVENUE ANALYSIS

14.16.3 GEOGRAPHIC PRESENCE

14.16.4 PRODUCT PORTFOLIO

14.16.5 RECENT DEVELOPMENTS

14.17 KONINKLIJKE PHILIPS

14.17.1 COMPANY OVERVIEW

14.17.2 REVENUE ANALYSIS

14.17.3 GEOGRAPHIC PRESENCE

14.17.4 PRODUCT PORTFOLIO

14.17.5 RECENT DEVELOPMENTS

14.18 SOC TELEMED

14.18.1 COMPANY OVERVIEW

14.18.2 REVENUE ANALYSIS

14.18.3 GEOGRAPHIC PRESENCE

14.18.4 PRODUCT PORTFOLIO

14.18.5 RECENT DEVELOPMENTS

14.19 TELADOC HEALTH

14.19.1 COMPANY OVERVIEW

14.19.2 REVENUE ANALYSIS

14.19.3 GEOGRAPHIC PRESENCE

14.19.4 PRODUCT PORTFOLIO

14.19.5 RECENT DEVELOPMENTS

14.2 AVEL ECARE

14.20.1 COMPANY OVERVIEW

14.20.2 REVENUE ANALYSIS

14.20.3 GEOGRAPHIC PRESENCE

14.20.4 PRODUCT PORTFOLIO

14.20.5 RECENT DEVELOPMENTS

14.21 CEIBA HEALTH

14.21.1 COMPANY OVERVIEW

14.21.2 REVENUE ANALYSIS

14.21.3 GEOGRAPHIC PRESENCE

14.21.4 PRODUCT PORTFOLIO

14.21.5 RECENT DEVELOPMENTS

14.22 CLEW

14.22.1 COMPANY OVERVIEW

14.22.2 REVENUE ANALYSIS

14.22.3 GEOGRAPHIC PRESENCE

14.22.4 PRODUCT PORTFOLIO

14.22.5 RECENT DEVELOPMENTS

14.23 CLOUDPHYSICIAN

14.23.1 COMPANY OVERVIEW

14.23.2 REVENUE ANALYSIS

14.23.3 GEOGRAPHIC PRESENCE

14.23.4 PRODUCT PORTFOLIO

14.23.5 RECENT DEVELOPMENTS

14.24 CRITINEXT

14.24.1 COMPANY OVERVIEW

14.24.2 REVENUE ANALYSIS

14.24.3 GEOGRAPHIC PRESENCE

14.24.4 PRODUCT PORTFOLIO

14.24.5 RECENT DEVELOPMENTS

14.25 IMDSOFT

14.25.1 COMPANY OVERVIEW

14.25.2 REVENUE ANALYSIS

14.25.3 GEOGRAPHIC PRESENCE

14.25.4 PRODUCT PORTFOLIO

14.25.5 RECENT DEVELOPMENTS

14.26 REMOTEICU

14.26.1 COMPANY OVERVIEW

14.26.2 REVENUE ANALYSIS

14.26.3 GEOGRAPHIC PRESENCE

14.26.4 PRODUCT PORTFOLIO

14.26.5 RECENT DEVELOPMENTS

14.27 SRI LAXMI KRAVIA TECHLABS

14.27.1 COMPANY OVERVIEW

14.27.2 REVENUE ANALYSIS

14.27.3 GEOGRAPHIC PRESENCE

14.27.4 PRODUCT PORTFOLIO

14.27.5 RECENT DEVELOPMENTS

14.28 VEEONE HEALTH

14.28.1 COMPANY OVERVIEW

14.28.2 REVENUE ANALYSIS

14.28.3 GEOGRAPHIC PRESENCE

14.28.4 PRODUCT PORTFOLIO

14.28.5 RECENT DEVELOPMENTS

14.29 ENEXT ICU

14.29.1 COMPANY OVERVIEW

14.29.2 REVENUE ANALYSIS

14.29.3 GEOGRAPHIC PRESENCE

14.29.4 PRODUCT PORTFOLIO

14.29.5 RECENT DEVELOPMENTS

14.3 INOVA

14.30.1 COMPANY OVERVIEW

14.30.2 REVENUE ANALYSIS

14.30.3 GEOGRAPHIC PRESENCE

14.30.4 PRODUCT PORTFOLIO

14.30.5 RECENT DEVELOPMENTS

14.31 T-ICU

14.31.1 COMPANY OVERVIEW

14.31.2 REVENUE ANALYSIS

14.31.3 GEOGRAPHIC PRESENCE

14.31.4 PRODUCT PORTFOLIO

14.31.5 RECENT DEVELOPMENTS

14.32 GENERAL VISION INC.

14.32.1 COMPANY OVERVIEW

14.32.2 REVENUE ANALYSIS

14.32.3 GEOGRAPHIC PRESENCE

14.32.4 PRODUCT PORTFOLIO

14.32.5 RECENT DEVELOPMENTS

14.33 NVIDIA CORPORATION

14.33.1 COMPANY OVERVIEW

14.33.2 REVENUE ANALYSIS

14.33.3 GEOGRAPHIC PRESENCE

14.33.4 PRODUCT PORTFOLIO

14.33.5 RECENT DEVELOPMENTS

14.34 IBM CORPORATION

14.34.1 COMPANY OVERVIEW

14.34.2 REVENUE ANALYSIS

14.34.3 GEOGRAPHIC PRESENCE

14.34.4 PRODUCT PORTFOLIO

14.34.5 RECENT DEVELOPMENTS

14.35 AICURE

14.35.1 COMPANY OVERVIEW

14.35.2 REVENUE ANALYSIS

14.35.3 GEOGRAPHIC PRESENCE

14.35.4 PRODUCT PORTFOLIO

14.35.5 RECENT DEVELOPMENTS

14.36 ICARBONX

14.36.1 COMPANY OVERVIEW

14.36.2 REVENUE ANALYSIS

14.36.3 GEOGRAPHIC PRESENCE

14.36.4 PRODUCT PORTFOLIO

14.36.5 RECENT DEVELOPMENTS

14.37 CYRCADIA HEALTH INC.

14.37.1 COMPANY OVERVIEW

14.37.2 REVENUE ANALYSIS

14.37.3 GEOGRAPHIC PRESENCE

14.37.4 PRODUCT PORTFOLIO

14.37.5 RECENT DEVELOPMENTS

14.38 ATOMWISE, INC.

14.38.1 COMPANY OVERVIEW

14.38.2 REVENUE ANALYSIS

14.38.3 GEOGRAPHIC PRESENCE

14.38.4 PRODUCT PORTFOLIO

14.38.5 RECENT DEVELOPMENTS

14.39 PATHWAY GENOMICS CORPORATION

14.39.1 COMPANY OVERVIEW

14.39.2 REVENUE ANALYSIS

14.39.3 GEOGRAPHIC PRESENCE

14.39.4 PRODUCT PORTFOLIO

14.39.5 RECENT DEVELOPMENTS

14.4 ZEBRA MEDICAL VISION LTD.

14.40.1 COMPANY OVERVIEW

14.40.2 REVENUE ANALYSIS

14.40.3 GEOGRAPHIC PRESENCE

14.40.4 PRODUCT PORTFOLIO

14.40.5 RECENT DEVELOPMENTS

14.41 SOPHIA GENETICS

14.41.1 COMPANY OVERVIEW

14.41.2 REVENUE ANALYSIS

14.41.3 GEOGRAPHIC PRESENCE

14.41.4 PRODUCT PORTFOLIO

14.41.5 RECENT DEVELOPMENTS

14.42 APIXIO INC.

14.42.1 COMPANY OVERVIEW

14.42.2 REVENUE ANALYSIS

14.42.3 GEOGRAPHIC PRESENCE

14.42.4 PRODUCT PORTFOLIO

14.42.5 RECENT DEVELOPMENTS

14.43 MICROSOFT

14.43.1 COMPANY OVERVIEW

14.43.2 REVENUE ANALYSIS

14.43.3 GEOGRAPHIC PRESENCE

14.43.4 PRODUCT PORTFOLIO

14.43.5 RECENT DEVELOPMENTS

14.44 INTEL CORPORATION

14.44.1 COMPANY OVERVIEW

14.44.2 REVENUE ANALYSIS

14.44.3 GEOGRAPHIC PRESENCE

14.44.4 PRODUCT PORTFOLIO

14.44.5 RECENT DEVELOPMENTS

14.45 DEEPMIND TECHNOLOGIES LIMITED

14.45.1 COMPANY OVERVIEW

14.45.2 REVENUE ANALYSIS

14.45.3 GEOGRAPHIC PRESENCE

14.45.4 PRODUCT PORTFOLIO

14.45.5 RECENT DEVELOPMENTS

14.46 VIZ.AI, INC.

14.46.1 COMPANY OVERVIEW

14.46.2 REVENUE ANALYSIS

14.46.3 GEOGRAPHIC PRESENCE

14.46.4 PRODUCT PORTFOLIO

14.46.5 RECENT DEVELOPMENTS

14.47 SUBTLE MEDICAL, INC.

14.47.1 COMPANY OVERVIEW

14.47.2 REVENUE ANALYSIS

14.47.3 GEOGRAPHIC PRESENCE

14.47.4 PRODUCT PORTFOLIO

14.47.5 RECENT DEVELOPMENTS

14.48 CLOUDMEDX INC.

14.48.1 COMPANY OVERVIEW

14.48.2 REVENUE ANALYSIS

14.48.3 GEOGRAPHIC PRESENCE

14.48.4 PRODUCT PORTFOLIO

14.48.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

15 RELATED REPORTS

16 QUESTIONNAIRE

17 CONCLUSION

18 ABOUT DATA BRIDGE MARKET RESEARCH